BPG is committed to discovery and dissemination of knowledge
Article Citation
Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol 2022; 14(2): 411-419 [PMID: 35317183 DOI: 10.4254/wjh.v14.i2.411]
Please LOGIN to submit a new comment.
Write to the Help Desk